Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DarioHealth Corp. stock logo
DRIO
DarioHealth
$0.55
-4.0%
$0.69
$0.50
$1.55
$24.45M1.24173,314 shs116,368 shs
Femasys Inc. stock logo
FEMY
Femasys
$0.82
-1.2%
$0.90
$0.69
$1.80
$26.97M-2.56153,605 shs136,252 shs
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
$2.02
-0.5%
$2.05
$1.72
$4.74
$6.55M0.9416,931 shs26,397 shs
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
$5.18
+19.6%
$3.85
$1.97
$7.95
$25.50M7.03428,007 shs981,899 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DarioHealth Corp. stock logo
DRIO
DarioHealth
-4.03%-15.56%-22.56%-26.68%-49.08%
Femasys Inc. stock logo
FEMY
Femasys
-1.16%-8.93%-13.71%-29.34%-27.47%
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
-0.05%-3.81%+2.54%-9.42%-58.09%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
+19.63%-1.15%+35.25%+89.74%+125.22%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
DarioHealth Corp. stock logo
DRIO
DarioHealth
1.8623 of 5 stars
3.31.00.00.00.00.81.3
Femasys Inc. stock logo
FEMY
Femasys
2.7852 of 5 stars
3.55.00.00.00.02.50.6
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
3.1816 of 5 stars
3.54.00.00.00.01.71.3
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
0.4445 of 5 stars
1.32.00.00.01.60.00.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
DarioHealth Corp. stock logo
DRIO
DarioHealth
2.67
Moderate Buy$2.00263.70% Upside
Femasys Inc. stock logo
FEMY
Femasys
3.00
Buy$8.67957.43% Upside
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
3.00
Buy$5.00147.52% Upside
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
2.50
Moderate Buy$4.82-7.01% Downside

Current Analyst Ratings Breakdown

Latest STRR, FEMY, DRIO, and VVOS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/25/2025
Femasys Inc. stock logo
FEMY
Femasys
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$12.00
6/11/2025
Femasys Inc. stock logo
FEMY
Femasys
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$12.00
5/20/2025
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
Industrial Alliance Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$2.25
5/20/2025
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
5/19/2025
DarioHealth Corp. stock logo
DRIO
DarioHealth
Litchfield Hills Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$3.00
5/15/2025
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$8.00 ➝ $5.00
5/13/2025
Femasys Inc. stock logo
FEMY
Femasys
Jones Trading
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$10.00 ➝ $6.00
5/9/2025
Femasys Inc. stock logo
FEMY
Femasys
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $12.00
(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
DarioHealth Corp. stock logo
DRIO
DarioHealth
$28.03M0.87N/AN/A$2.11 per share0.26
Femasys Inc. stock logo
FEMY
Femasys
$1.70M15.69N/AN/A$0.10 per share8.20
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
$53.36M0.12$0.32 per share6.23$10.98 per share0.18
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
$15.03M2.03N/AN/A$1.35 per share3.84
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
DarioHealth Corp. stock logo
DRIO
DarioHealth
-$42.75M-$0.56N/AN/AN/A-159.80%-65.81%-38.41%8/6/2025 (Estimated)
Femasys Inc. stock logo
FEMY
Femasys
-$18.82M-$0.91N/AN/AN/A-1,242.06%-392.45%-137.15%8/14/2025 (Estimated)
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
-$10.44M-$3.43N/AN/AN/A-16.43%-8.24%-3.48%8/12/2025 (Estimated)
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
-$11.14M-$1.73N/AN/AN/A-76.82%-170.43%-77.82%8/13/2025 (Estimated)

Latest STRR, FEMY, DRIO, and VVOS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025
DarioHealth Corp. stock logo
DRIO
DarioHealth
-$0.11N/AN/AN/A$6.91 millionN/A
8/14/2025N/A
Femasys Inc. stock logo
FEMY
Femasys
-$0.18N/AN/AN/AN/AN/A
8/13/2025Q2 2025
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
-$0.39N/AN/AN/A$3.37 millionN/A
8/12/2025Q2 2025
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
-$0.26N/AN/AN/A$16.75 millionN/A
5/15/2025Q1 2025
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
-$0.44-$0.45-$0.01-$0.45$3.63 million$3.70 million
5/14/2025Q1 2025
DarioHealth Corp. stock logo
DRIO
DarioHealth
-$0.07-$0.14-$0.07-$0.14$7.48 million$6.75 million
5/14/2025Q1 2025
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
-$0.25-$0.52-$0.27-$0.37$16.35 million$12.92 million
5/8/2025Q1 2025
Femasys Inc. stock logo
FEMY
Femasys
-$0.17-$0.23-$0.06-$0.23$1.14 million$0.34 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
DarioHealth Corp. stock logo
DRIO
DarioHealth
N/AN/AN/AN/AN/A
Femasys Inc. stock logo
FEMY
Femasys
N/AN/AN/AN/AN/A
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
N/AN/AN/AN/AN/A
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
DarioHealth Corp. stock logo
DRIO
DarioHealth
0.26
2.01
1.77
Femasys Inc. stock logo
FEMY
Femasys
0.02
0.93
0.54
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
0.22
1.42
0.88
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
N/A
0.77
0.77

Institutional Ownership

CompanyInstitutional Ownership
DarioHealth Corp. stock logo
DRIO
DarioHealth
33.39%
Femasys Inc. stock logo
FEMY
Femasys
65.27%
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
3.84%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
26.35%

Insider Ownership

CompanyInsider Ownership
DarioHealth Corp. stock logo
DRIO
DarioHealth
11.20%
Femasys Inc. stock logo
FEMY
Femasys
11.54%
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
33.51%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
3.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
DarioHealth Corp. stock logo
DRIO
DarioHealth
20044.46 million39.48 millionOptionable
Femasys Inc. stock logo
FEMY
Femasys
3032.53 million28.77 millionNot Optionable
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
4603.23 million2.15 millionNot Optionable
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
1605.89 million5.71 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

DarioHealth stock logo

DarioHealth NASDAQ:DRIO

$0.55 -0.02 (-4.03%)
Closing price 08/1/2025 03:56 PM Eastern
Extended Trading
$0.54 -0.01 (-1.62%)
As of 08/1/2025 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Femasys stock logo

Femasys NASDAQ:FEMY

$0.82 -0.01 (-1.16%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$0.81 -0.01 (-1.05%)
As of 08/1/2025 06:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

Star Equity stock logo

Star Equity NASDAQ:STRR

$2.02 -0.01 (-0.49%)
As of 08/1/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Star Equity Holdings, Inc. engages in the construction business in the United States and internationally. It operates through two segments: Construction, and Investments. It manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; holds real estate assets; and manages investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut.

Vivos Therapeutics stock logo

Vivos Therapeutics NASDAQ:VVOS

$5.18 +0.85 (+19.63%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$5.18 0.00 (-0.10%)
As of 08/1/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.